Document Details

MGEN $2.65 $ - 0.05 (1.85%)
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 12/4/2018
Filing Date 12/6/2018

Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Other Events; and Financial Statements and Exhibits.

File Section(s)

  1. FORM 8-K
  2. EX-99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.